WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year,…
Coldbest cough syrup: The faults and the lessons
What went wrong with the Coldbest cough syrup that affected 17 children and killed 12 of them in Jammu and Kashmir? It’s the…
Finding the silver lining about coronavirus pandemic
As India Pharma Inc reels under the far-reaching impact of the coronavirus epidemic, industry experts suggest policy reforms to…
PPL Conclave 2020
Pharma Packaging and Labelling (PPL) Conclave, in its third edition, witnesses a confluence of pharma leaders and innovators…
Making India a $100 bn biomanufacturing hub by 2024
Industry experts outline how Prime Minister Narendra Modi's dream of 'Make in India' for the biomanufacturing sector can be…
Carcinogens under the scan
As trace amounts of cancer causing contaminants continue to crop up in certain medicines, pharma companies are upgrading their…
Rare Diseases: Awaiting renewed focus
India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of…
Unlocking Potential
Experts outline plans of action for capability expansion, reforms and market leadership to step up India Pharma Inc's growth…
2020 and beyond: Key trends impacting the labelling market
By Ken Moir, VP Marketing, NiceLabel highlights that there is a pipeline of new opportunities for global labelling solutions or…
Encouraging patient-centric innovation in pharma
Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions Enterprise) emphasises that patient…
Trends in retail pharma for 2020 and beyond
Arushi Jain, Executive Director, StayHappi Pharmacy explains how technological advancements would play a crucial role in the…
“Patient-centric marketing will become a fundamental pillar in the future of pharma marketing”
Sumita Mohapatro Pani, Senior General Manager, Lupin speaks to Viveka Roychowdhury on the rewriting of the pharma sales and…
Patient-centric innovation – catering to future needs
Manoj Saxena, Managing Director, Bayer Zydus Pharma, talks about how technology has become an essential tool that complements the…
The Indian Pharmaceutical Industry: Pride and Growth Lever of India
Sudarshan Jain, Secretary General, IPA and Archana Jatkar, Associate Secretary General, IPA reminisce on five significant steps…
25th anniversary special: ‘Celebrating Progress’
Over the past 25 years, Express Pharma has been faithfully tracking and capturing the pulse of the life sciences industry. Be it…
Empowering Indian Pharma with IIoT
India Pharma Inc needs to arm itself with a forward-looking attitude, strategic roadmap, significant investments and meaningful…
Co-creating a smart ecosystem for pharma
India Pharma Inc needs to build a more efficient and innovation-centric ecosystem which is aligned with global trends and…
Next-gen workforce for a digital era
The need for the right people in the right place has emerged as one of the principal drivers of success in the digital era, making…
Bolstering Sikkim’s growth
Sikkim needs to re-strategise to develop newer capabilities and scale-up its growth to retain its position as a pharma hub